Abeona Therapeutics Inc. (ABEO)
Abeona Therapeutics Statistics
Share Statistics
Abeona Therapeutics has 48.53M shares outstanding. The number of shares has increased by 58.91% in one year.
| Shares Outstanding | 48.53M |
| Shares Change (YoY) | 58.91% |
| Shares Change (QoQ) | 0.36% |
| Owned by Institutions (%) | 0% |
| Shares Floating | 42.86M |
| Failed to Deliver (FTD) Shares | 173 |
| FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 2.64M, so 6.07% of the outstanding shares have been sold short.
| Short Interest | 2.64M |
| Short % of Shares Out | 6.07% |
| Short % of Float | 6.82% |
| Short Ratio (days to cover) | 10.79 |
Valuation Ratios
The PE ratio is -3.59 and the forward PE ratio is -4.81. Abeona Therapeutics's PEG ratio is 0.09.
| PE Ratio | -3.59 |
| Forward PE | -4.81 |
| PS Ratio | 0 |
| Forward PS | 0.6 |
| PB Ratio | 5.19 |
| P/FCF Ratio | -3.91 |
| PEG Ratio | 0.09 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Abeona Therapeutics Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.08, with a Debt / Equity ratio of 0.52.
| Current Ratio | 6.08 |
| Quick Ratio | 6.08 |
| Debt / Equity | 0.52 |
| Total Debt / Capitalization | 34.36 |
| Cash Flow / Debt | -2.43 |
| Interest Coverage | 15.26 |
Financial Efficiency
Return on equity (ROE) is -1.45% and return on capital (ROIC) is -95.72%.
| Return on Equity (ROE) | -1.45% |
| Return on Assets (ROA) | -0.59% |
| Return on Capital (ROIC) | -95.72% |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-468,632.35 |
| Employee Count | 136 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -30.48% in the last 52 weeks. The beta is 1.78, so Abeona Therapeutics's price volatility has been higher than the market average.
| Beta | 1.78 |
| 52-Week Price Change | -30.48% |
| 50-Day Moving Average | 5.41 |
| 200-Day Moving Average | 5.53 |
| Relative Strength Index (RSI) | 40.77 |
| Average Volume (20 Days) | 331.77K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -64.21M |
| Net Income | -63.73M |
| EBITDA | -64.21M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1.55 |
Balance Sheet
The company has 23.36M in cash and 23.05M in debt, giving a net cash position of 309K.
| Cash & Cash Equivalents | 23.36M |
| Total Debt | 23.05M |
| Net Cash | 309K |
| Retained Earnings | -813.26M |
| Total Assets | 108.93M |
| Working Capital | 84.27M |
Cash Flow
In the last 12 months, operating cash flow was -56.02M and capital expenditures -2.45M, giving a free cash flow of -58.46M.
| Operating Cash Flow | -56.02M |
| Capital Expenditures | -2.45M |
| Free Cash Flow | -58.46M |
| FCF Per Share | -1.42 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ABEO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -30.75% |
| FCF Yield | -23.88% |
Analyst Forecast
The average price target for ABEO is $17, which is 237.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $17 |
| Price Target Difference | 237.3% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Jul 5, 2022. It was a backward split with a ratio of 1:25.
| Last Split Date | Jul 5, 2022 |
| Split Type | backward |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | -9.32 |
| Piotroski F-Score | 2 |